Lucira Health Past Earnings Performance
Past criteria checks 0/6
Lucira Health's earnings have been declining at an average annual rate of -93.1%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 558.8% per year.
Key information
-93.1%
Earnings growth rate
-24.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 558.8% |
| Return on equity | -235.3% |
| Net Margin | -67.5% |
| Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
Recent updates
Lucira Health reports early data for point of care chlamydia and gonorrhea assays
Sep 29Lucira COVID & Flu test gets emergency use authorization from Health Canada
Aug 11Lucira Health Sees Strong Revenue Growth But Needs More Cash
Mar 10Analysts' Revenue Estimates For Lucira Health, Inc. (NASDAQ:LHDX) Are Surging Higher
Nov 25
Is Lucira Health (NASDAQ:LHDX) In A Good Position To Invest In Growth?
Jun 29Lucira Health appoints medtech veteran Kevin Collins as CRO
May 28Health Canada issues 'authorization with conditions' for Lucira's COVID-19 test kit
Apr 26Revenue & Expenses BreakdownBeta
How Lucira Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 212 | -143 | 57 | 41 |
| 30 Jun 22 | 193 | -44 | 52 | 46 |
| 31 Mar 22 | 179 | -38 | 39 | 45 |
| 31 Dec 21 | 93 | -65 | 31 | 40 |
| 30 Sep 21 | 32 | -74 | 26 | 39 |
| 30 Jun 21 | 17 | -59 | 16 | 34 |
| 31 Mar 21 | 5 | -49 | 11 | 28 |
| 31 Dec 20 | 0 | -37 | 6 | 25 |
| 30 Sep 20 | 0 | -22 | 4 | 19 |
| 31 Dec 19 | 0 | -8 | 2 | 11 |
Quality Earnings: LHDX.Q is currently unprofitable.
Growing Profit Margin: LHDX.Q is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if LHDX.Q's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare LHDX.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LHDX.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).
Return on Equity
High ROE: LHDX.Q has a negative Return on Equity (-235.31%), as it is currently unprofitable.